Association of fatty acid desaturase gene polymorphisms with blood lipid essential fatty acids and perinatal depression among canadian women: A pilot study

Journal of Nutrigenetics and Nutrigenomics

Volumn 2, Issue 4-5, 2010, Pages 243-250

  Xie, Lin ^a   Innis, Sheila M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Eicosapentaenoic acid; Fatty acid desaturase gene; Perinatal depression; Single nucleotide polymorphisms

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; ACYL COENZYME A DESATURASE 2; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; ETHANOLAMINE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANADA; EDINBURGH POSTNATAL DEPRESSION SCALE; FATTY ACID BLOOD LEVEL; FEMALE; GENETIC VARIABILITY; GENOTYPE; GESTATIONAL AGE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PILOT STUDY; PRIORITY JOURNAL; PUERPERAL DEPRESSION; QUANTITATIVE TRAIT; RISK ASSESSMENT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

CANADA; DEPRESSION; DEPRESSION, POSTPARTUM; DEPRESSIVE DISORDER; FATTY ACID DESATURASES; FATTY ACIDS, ESSENTIAL; FEMALE; HUMANS; LIPIDS; MULTIGENE FAMILY; PERINATOLOGY; PILOT PROJECTS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY;

EID: 77950814664     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000255636     Document Type: Article

References (60)

1. Marcus SM: Depression during pregnancy: rates, risk and consequences - mother risk update 2008. Can J Clin Pharmacol 2009; 16:e15-e22.
2. Leahy-Warren P, McCarthy G: Postnatal depression: prevalence, mothers' perspectives, and treatments. Arch Psychiatr Nurse 2007; 21: 91-100.
3. Evans J, Heron J, Francomb H, Oke S, Golding J: Cohort study of depressed mood during pregnancy and after childbirth. BMJ 2001; 323: 257-260. (Pubitemid 32729111)
4. Chabrol H, Callahan S: Prevention and treatment of postnatal depression. Expert Rev Neurother 2007; 7: 557-576.
5. Altshuler LL, Hendrick V, Cohen LS: Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry 1998; 59: 29-33.
6. Newport DJ, Wilcox MM, Stowe ZN: Maternal depression: a child's first adverse life event. Semin Clin Neuropsychiatry 2002; 7: 113-119.
7. Hibbeln JR, Nieminene LR, Balsbalg TL, Riggs JA, Lands WE: Healthy intakes of n-3 and n-6 fatty acids: estimations from world wide diversity. Am J Clin Nutr 2006; 83: 1483S-1493S.
8. Hibbeln JR: Depression, suicide and deficiencies of omega-3 fatty acids in modern diets. World Rev Nutr Diet 2009; 99: 17-30.
9. Lakhan SE, Vieira KF: Nutritional therapies for mental disorders. Nutr J 2008; 7: 2.
10. Su KP: Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'? Neurosignals 2009; 17: 144-152.
11. Kiecolt-Glaser JK, Belury MA, Porter MA, Beversdorf DQ, Lemeshow S, Glaser R: Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosom Med 2007; 69: 217-224.
12. Chalon S: Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 259-269.
13. Innis SM: Dietary (n-3) fatty acids and brain development. J Nutr 2007; 137: 855-859.
14. Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C, Nellemann C, Hansen SH, Hansen HS: Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 2008; 1781: 200-212.
15. Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V: Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci USA 2001; 98: 6402-6406.
16. Rees AM, Austin MP, Owen C, Parker G: Omega-3 deficiency associated with perinatal depression: case control study. Psychiatry Res 2009; 166: 254-259.
17. Schiepers OJ, de Groot RH, Jolles J, van Boxtel MP: Plasma phospholipid fatty acid status and depressive symptoms: association only present in the clinical range. J Affect Disord 2009; 118: 209-214.
18. Adams PB, Lawson S, Sanigorski A, Sinclair AJ: Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996; 31:S157-S161.
19. Edwards R, Peet M, Shay J, Horrobin DJ: Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. Affect Disord 1998; 48: 149-155. (Pubitemid 28244216)
20. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY: Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999; 275-291.
21. Hibbeln JR: Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 2002; 69: 15-29.
22. Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ: Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006; 113: 31-35.
23. Appleton KM, Gunnell D, Peters T, Ness AR, Kessler D, Rogers PJ: No clear evidence of an association between plasma concentrations of long-chain polyunsaturated fatty acids and depressed mood in a non-clinical population. Prostaglandins Leukot Essent Fatty Acids 2008; 78: 337-342.
24. Golding J, Steer C, Emmett P, Davis JM, Hibbeln JR: High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology 2009; 20: 598-603.
25. Sonkrop J, Avison WR, Evers SE, Speechley KN, Campbell MK: Depressive symptoms during pregnancy in relation to fish consumption and intake for n-3 polyunsaturated fatty acids. Paediatr Perinat Epidemiol 2008; 22: 389-399.
26. Miyake Y, Sasaki S, Yokoyama T, Tanaka K, Ohya Y, Fukushima W, Saito K, Ohfuji S, Kiyohara C, Hirota Y: Risk of postpartum depression in relation to dietary fish and fat intake in Japan. The Osaka Maternal and Child Health Study. Psychol Med 2006; 36: 1727-1735.
27. Doornbos B, van Goor SA, Dijck-Brouwer DA, Schaafsma A, Korf J, Muskiet FA: Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small populationbased sample. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 49-52.
28. Lucas M, Asselin G, Merette C, Poulin MJ, Dodin S: Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Am J Clin Nutr 2009; 89: 641-651.
29. Stahl LA, Begg DP, Weisinger RS, Sinclair AJ: The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs 2008; 9: 57-64.
30. Maes M, Maylova I, Kubera M, Bosmans E: Why fish oils may not always be adequate treatments for depression or other inflammatory illnesses: docosahexaenoic acid, an omega-3 polyunsaturated fatty acids, induces Th-1-like immune response. Neuroendocrinol Lett 2007; 28: 875-880.
31. DeMar JC, Lee HJ, Ma K, Chang L, Bell JM, Rapoport SI, Bazinet RP: Brain elongation of linoleic acid is a negligible source of arachidonate in brain phospholipids of adult rats. Biochim Biophys Acta 2006; 16: 1050-1059.
32. Gao F, Kiesewetter D, Chang L, Ma K, Bell JM, Rapoport SI, Igarashi M: Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified-linolenic acid in unanesthetized rats. J Lipid Res 2009; 50: 749-758.
33. Cho HP, Nakamura MT, Clarke SD: Cloning, expression, and nutritional regulation of the mammalian-6 desaturase. J Biol Chem 1999; 274: 471-477.
34. Cho HP, Nakamura M, Clarke SD: Cloning, expression, and fatty acid regulation of the human-5 desaturase. J Biol Chem 1999; 274: 37335-37339.
35. Nakamura MT, Nara TY: Structure, function, and dietary regulation of-6,-5, and-9 desaturases. Annu Rev Nutr 2004; 24: 345-376.
36. Schaeffer L, Gohlke H, Muller M, Heid IM, Palmer LJ: Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006; 15: 1745-1756.
37. Schaeffer L, Xumerle L, Klopp N, Trabetti E: SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008; 43: 288-299.
38. Xie L, Innis SM: Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J Nutr 2008; 138: 2222-2228.
39. Malerba G, Schaeffer L, Xumerle L, Klopp N, Trabetti E, Biscuola M, Cavallari U, Galavotti R, Martinelli N, Guarini P, et al: SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008; 43: 289-299.
40. Innis SM, Friesen RW: Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr 2008; 87: 548-557.
41. Innis SM, Elias SL: Intakes of essential n-6 and n-3 polyunsaturated fatty acids among pregnant Canadian women. Am J Clin Nutr 2003; 77: 473-478.
42. Cox JL, Holden JM, Sagovsky R: Detection of postnatal depression development of the 10-Item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150: 782-786.
43. Cox JL, Chapman G, Murray D, Jones P: Validation of the Edinburgh Postnatal Depression Scale in non-postnatal women. J Affect Disord 1996; 39: 185-189.
44. Hanusa BH, Scholle SH, Haskett RF, Spadaro K, Wisner KL: Screening for depression in the postpartum period: a comparison of three instruments. J Womens Health 2008; 17: 585-596.
45. Elias SL, Innis SM: Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr 2001; 73: 807-814.
46. Innis SM, Gilley J, Werker J: Are human milk long-chain polyunsaturated fatty acids related to visual and neural development in breast-fed term infants? J Pediatr 2001; 139: 532-538.
47. Marquardt A, Stohr H, White K, Weber BH: CDNA cloning, genomic structure and chromosomal localization of three members of the human fatty acid desaturase family. Genomics 2000; 66: 175-183.
48. Nesheim MC, Yaktine AL (eds): Committee on Nutrient Relationships in Seafood: Selections to Balance Benefits and Risks. Washington, National Academies Press, 2007.
49. Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ: Circulating endocannabinoids and N-acyl-ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 2009; 34: 1257-1262.
50. Hill MN, Miller GE, Ho WS, Gorzalka BB, Hillard CJ: Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry 2008; 41: 48-53.
51. Yang H, Chen C: Cyclooxygenase-2 in synaptic signaling. Curr Pharm Des 2008; 14: 1443-1451.
52. Caspi A, Williams B, Kim-Cohen J, Craig IW, Milne BJ, Poulton R, Schalkwyk LC, Taylor A, Werts H, Moffitt TE: Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci USA 2007; 104: 18860-18865.
53. Shimano H: Sterol regulatory element-binding proteins: transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001; 40: 439-452.
54. Weber LW, Boll M, Stampfl A: Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. World J Gastroeneterol 2004; 10: 3081-3087.
55. Yoshikawa T, Shimano H, Yahagi N, Ide T, Amemiya-Kudo M, Matsuzaka T, Nakakuki M, Tomita S, Okazaki H, Tamura Y, et al: Polyunsaturated fatty acids suppress regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor binding to RXR response elements. J Biol Chem 2002; 277: 1705-1711.
56. Liou AY, Innis SM: Dietary linoleic acid has no effect on arachidonic acid, but increases n-6 eicosadienoic acid, and lowers dihomo-linolenic and eicosapentaenoic acid in plasma of adult men. Prostaglandins Leukot Essent Fatty Acids 2009;80:201-206.
57. Troisi A: Cholesterol in coronary heart disease and psychiatric disorders: same or opposite effects on morbidity risk? Neurosci Biobehav Rev 2009; 33: 125-132.
58. Harris WS: Linoleic acid and coronary heart disease. Prostaglandins Leukot Essent Fatty Acids 2008; 79: 169-171.
59. Chatterjee S, Szustakowski JD, Nanguneri NR, Mickanin C, Labow MA, Nohturfft A, Dev KK, Sivasankaran R: Identification of novel genes and pathways regulating SREBP transcriptional activity. PLoS ONE 2009; 4:e5197.
60. Deng X, Cagen LM, Wilcox HG, Park EA, Raghow R, Elam MB: Regulation of the rat SREBP-1c promoter in primary rat hepatocytes. Biochem Biophys Res Commun 2002; 290: 256-262